Full-Time

EHSS Engineer 3

Updated on 9/11/2026

Integer Holdings Corporation

Integer Holdings Corporation

1,001-5,000 employees

Medical device CDMO for cardiac devices

No salary listed

Pembroke Pines, FL, USA

In Person

Bachelor's

Category
Facilities Operations (1)
Required Skills
Microsoft Office
CPR
First Aid

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Requirements
  • A bachelor's degree in environmental, natural, or equivalent science; engineering technology; occupational safety or industrial hygiene; or fire safety, or 3–5 years of accumulated EHSS learning and experience.
  • Professional certifications such as Certified Safety Professional or Certified Industrial Hygienist are preferred.
  • Ability to collaborate with other departments to meet common goals related to company strategy.
  • A calm demeanor in a high-energy, constantly changing production environment.
  • Expanded knowledge of the physical properties and hazards of chemicals.
  • Strong organization, recordkeeping, interpersonal, and work-direction skills.
  • Proficiency with personal computers, Microsoft Office, and electronic Safety Management Systems.
Responsibilities
  • Support systems and drive execution of programs that maintain a safe workplace and ensure compliance with applicable Environmental, Health, Safety, and Security regulations.
  • Adhere to Quality Management Systems, Safety, Environmental and Security Management Systems, U.S. Food and Drug Administration regulations, company policies, operating procedures, and other regulatory requirements.
  • Serve as the subject matter expert on associate safety, environmental protection, process safety, equipment safety, and security in a manufacturing environment.
  • Collaborate with the EHSS Manager and peers to implement the site-specific EHSS strategy, programs, and initiatives.
  • Monitor and evaluate new laws, regulations, and industry standards and implement them into the site EHSS program.
  • Lead cross-functional teams to achieve a safe and environmentally friendly work environment.
  • Maintain and prepare records, permits, and reports according to guidelines established by local, county, state, and country agencies.
  • Develop and implement training for new and existing associates on company policies, procedures, and governmental regulations.
  • Identify hazardous workplace conditions through documented job hazard analyses and coordinate corrective and preventive actions.
  • Respond to day-to-day associate concerns appropriately and promptly.
  • Manage investigations of serious work-related injuries and near-miss incidents, document findings, root-cause analyses, and corrective actions, and manage workers' compensation claims and timely return to work.
  • Lead EHSS reviews, measurements, audits, and reports assigned by the EHSS Manager to maintain compliance with EHSS laws, regulations, company policies, and best practices.
  • Lead and train the Emergency Response Team in hazmat, incipient fire, medical, and other potential emergency response areas.
  • Serve as liaison to government agencies, emergency responders, and customers.
  • Lead safety committees and teams, ergonomics, management safety audits, recurring EHSS inspections, Behavioral Based Safety, and special skills and certifications.
  • Promote associate safety engagement through observations, suggestions, and near-miss reporting.
  • Assess new equipment and chemicals brought on site with the EHSS Manager.
  • Lead EHSS internal self-assessments and participate in internal and external inspections as needed.
  • Achieve safety engagement goals and sustain environmental, health, safety, and security initiatives.
  • Deliver scheduled tasks and milestones for assigned projects, complete committed results, support cost improvements and cost controls, and promote associate engagement and individual development plans.
Desired Qualifications
  • First Aid, CPR, AED, Laser Safety Officer, Forklift Trainer, or other relevant EHSS certifications are preferred.
Integer Holdings Corporation

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • KKR will pay $127 cash per share, a 51.8% premium.
  • Q2 2026 adjusted EPS hit $1.60, beating estimates by 15.9%.
  • KKR plans capacity, technology, innovation, and employee ownership investments after closing.

What critics are saying

  • New Ross shut for two unpaid weeks July 27-August 10, signaling demand volatility.
  • Q2 2026 sales fell 2.6% to $464.1 million, with organic sales down 1.5%.
  • Post-deal, Integer delists from NYSE and disappears if approvals or financing break.

What makes Integer Holdings Corporation unique

  • KKR’s August 3, 2026 bid validates Integer’s critical medtech CDMO platform.
  • Integer supplies components for cardiovascular, neuromodulation, and orthopedic devices across major manufacturers.
  • The New Ross facility remains strategically important, with recent capacity and technology investments.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Adoption Assistance

Parental Leave

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Company News

Ticker Report
Aug 29th, 2026
Boussard & Gavaudan Gestion Sas Makes New $2.60 Million Investment in Integer Holdings Corporation $ITGR

Boussard & Gavaudan Gestion Sas bought a new position in Integer Holdings Corporation (NYSE:ITGR – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 28,153 shares of the medical equipment provider’s stock, valued at approximately $2,597,000. Other institutional investors and hedge funds also […]

Yahoo Finance
Aug 16th, 2026
Healthcare stocks outpace S&P 500 by 13 percentage points over six months

Healthcare stocks have returned 26.1% over the past six months, outperforming the S&P 500 by 13.1 percentage points. However, investors must remain cautious due to heavy regulation affecting earnings potential. Integer Holdings faces concerns with 6.1% annual revenue growth over two years, lagging healthcare peers. Its modest revenue base of $1.84 billion provides less fixed cost leverage than larger competitors. The company trades at $125.07 per share, or 18.6 times forward price-to-earnings. Evolent Health shows weak platform performance and declining returns on capital. Its high net-debt-to-EBITDA ratio of 7 times could force unfavourable capital raises if market conditions worsen. Shares trade at $4.15, representing 12.4 times forward price-to-earnings. Tenet Healthcare, operating hospitals and surgical centres across nine US states, emerges as the recommended healthcare investment.

Yahoo Finance
Aug 4th, 2026
Integer Holdings acquired by KKR for $5.7B in all-cash deal at $127 per share

Integer Holdings agreed to be acquired by private equity firm KKR in an all-cash deal valued at approximately $5.7 billion. The transaction values the medical technology company at $127 per share. Shares jumped 2.7% in afternoon trading, continuing a rally from the previous session when the stock surged over 20% following the announcement. The acquisition news overshadowed strong second-quarter results, where Integer posted an adjusted profit of $1.60 per share on $464.1 million in revenue, surpassing analyst estimates. Following the buyout announcement, Integer withdrew its previously issued financial guidance and cancelled its upcoming earnings conference call. Shares traded at $124.50, marking a new 52-week high.

BizWire Express
Aug 3rd, 2026
KKR to acquire Integer for $5.7B in all-cash deal at $127 per share

KKR has agreed to acquire Integer Holdings Corporation, a medical device contract development and manufacturing organisation, in an all-cash transaction valued at approximately $5.7 billion. Integer stockholders will receive $127 per share, representing a 51.8% premium to the company's closing share price on 29 April 2026. The acquisition follows a comprehensive strategic review announced by Integer in April 2026. The Integer Board unanimously approved the agreement and recommends stockholder approval. KKR plans to invest in Integer's capacity, technology, innovation, and talent. The firm also intends to establish a broad-based employee ownership programme following the transaction's close, consistent with its approach across portfolio companies. The transaction is expected to close by year-end, subject to stockholder approval and regulatory clearances. Upon completion, Integer will become privately held and delist from the New York Stock Exchange.

Yahoo Finance
Aug 3rd, 2026
Integer Holdings beats Q2 expectations with $464M revenue and $1.60 earnings per share

Integer Holdings Corp. reported second-quarter net income of $23.6 million, or 69 cents per share. Adjusted earnings came to $1.60 per share, exceeding Wall Street expectations of $1.38 per share. The Plano, Texas-based medical device outsource manufacturer posted revenue of $464.1 million for the period, also beating analyst forecasts of $452.5 million. The results surpassed predictions from five analysts surveyed by Zacks Investment Research on both earnings and revenue metrics.